![Ely Benaim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Ely Benaim is Chief Medical Officer at NovoCure Ltd. In the past Dr. Benaim occupied the position of Vice President-Clinical Affairs at Sangamo Therapeutics, Inc., Chief Medical Officer & SVP-Regulatory Affairs at Berg Pharma LLC, Senior Director-Clinical Research at Millennium Pharmaceuticals, Inc., Chief Medical Officer of Rexahn Pharmaceuticals, Inc., Senior Director-Global Oncology at Salmedix, Inc. and Assistant Professor at the University of Tennessee. Dr. Benaim received a doctorate from Central University of Venezuela.
Former positions of Ely Benaim
| Companies | Position | End |
|---|---|---|
| NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 17/01/2023 |
| REXAHN PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2019 |
Berg Pharma LLC | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2010 |
Training of Ely Benaim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
27
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology and small molecule drugs to treat hematologic malignancies | Health Technology |
University of Tennessee
 University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Central University of Venezuela
 Central University of Venezuela Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Berg Pharma LLC |
- Stock Market
- Insiders
- Ely Benaim
